Stem Cell Differentiation into Corneal Endothelial Cells with Modified ECM

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

The limited supply of corneal donors and the inefficiency of existing methods to induce stem cells, such as induced pluripotent stem cells (iPSCs) and embryonic stem cells, into corneal endothelial cells (CECs) pose a challenge for treating corneal endothelial cell damage.

Innovation Solution

A method involving culturing stem cells in a culture vessel coated with a modified extracellular matrix (ECM) in the presence of a Rho-associated protein kinase (ROCK) inhibitor, using specific media compositions to differentiate stem cells into neural crest cells (NCCs) and then into corneal endothelial cells (CECs).

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If keratoplasty (donor tissue transplantation) is used to treat corneal endothelial cell damage, then the damage can be repaired, but the limited supply of corneal donors makes this treatment insufficient

Engineering Contradiction:

Improvetreatment effectivenessVSAvoiddonor tissue supply

Core Design Contradiction:

ReliabilityVSQuantity of substance

Solution Approach 1:

The patent creates copies of corneal endothelial cells by differentiating pluripotent stem cells (iPSCs or ESCs) into functional CECs in vitro. These differentiated cells serve as substitutes for donor tissue, providing an unlimited source of treatment material while maintaining therapeutic effectiveness

Inventive Principle:

Principle #26Copying

Solution Approach 2:

The patent enables self-service by using the patient's own pluripotent stem cells to generate corneal endothelial cells for transplantation. This autologous approach eliminates the need for external donor tissues, making the treatment self-sufficient

Inventive Principle:

Principle #25Self-service

2Productivity

If existing methods are used to induce stem cells into corneal endothelial cells, then some differentiation occurs, but the efficiency is insufficient for practical application

Engineering Contradiction:

Improvedifferentiation efficiencyVSAvoidcell functionality

Core Design Contradiction:

ProductivityVSReliability

Solution Approach 1:

The patent optimizes differentiation parameters including ROCK inhibitor concentration (e.g., 10 µM Y-27632), culture medium composition (specific growth factors and supplements), and culture conditions (temperature, CO2 levels) to maximize both differentiation efficiency and cell functionality

Inventive Principle:

Principle #35Parameter changes

Solution Approach 2:

The patent uses ROCK inhibitors as intermediary substances that block the Rho-associated protein kinase pathway, thereby preventing stress fiber formation and apoptosis during stem cell differentiation. This intermediary approach enhances survival rates and differentiation efficiency without compromising cell function

Inventive Principle:

Principle #24Intermediary (Mediator)

Data Source

PatentEP4636079A1Method for inducing differentiation of stem cells into corneal endothelial cells and use thereof

Publication Date: 2025.10.22 ETHICSTEM

Figure 1
Figure 2
Figure 3

AI summary

The present invention relates to a method of inducing differentiation of stem cells into corneal endothelial cells and use thereof. The method according to an aspect may increase, by using a composition for differentiation, the efficiency of differentiating stem cells into corneal endothelial cells. The differentiated corneal endothelial cells exhibit specific characteristics of corneal endothelial cells, and thus can be widely used as an alternative cell source for transplantation of corneal endothelial cells. Additionally, since FBS is not contained, stability in clinical trials may be improved.